Martine Rothblatt, CEO of United Therapeutics Corporation ($UTHR), sold 84,780 shares across 86 open-market transactions in July 2026. The sales yielded roughly $45.5 million, with per-share prices ranging from $518.25 to $563.24. The trades were disclosed in multiple filings with the Securities and Exchange Commission.
On July 30, the final trading day of the month, Rothblatt filed a Form 4 with the SEC reporting the sale of 4,846 shares at an average price of $524.88. That single block was worth approximately $2.54 million and was disclosed the next day, July 31. After the transaction, she held 326,967 shares. Across the full session, she executed six sales on July 30, unloading 9,500 shares for about $5.0 million. Prices that day fell between $523.04 and $528.96.
Other United Therapeutics insiders also sold in July. Director Jan Malcolm parted with 325 shares at $550.59 on July 10. Vice President Paul A. Mahon carried out eight sales on July 16, moving 8,300 shares at prices from $527.60 to $536.85. Mahon's combined proceeds were roughly $4.4 million.
Rothblatt's June trading was lighter: 18 sales, 18,480 shares, and about $9.95 million. The three months before that were far heavier. March 2026 saw 276 sales for 215,298 shares and $110.2 million in proceeds. In April, she logged 226 sales, 198,050 shares, and $113.5 million. May brought 189 sales, 159,080 shares, and $91.1 million. The pattern extended back into 2025. Between September and December, she sold between 57,000 and 87,000 shares each month.
No members of Congress disclosed $UTHR trades during 2026. The two most recent lawmakers active in the stock were Representatives Michael T. McCaul and Lisa Mcclain, who executed purchases and sales from 2022 through October 2025. Congressional dollar figures are midpoint estimates of the bracketed ranges required by the STOCK Act.
United Therapeutics, headquartered in Silver Spring, Maryland, is a biotechnology company focused on developing therapies for pulmonary arterial hypertension and other chronic conditions. During July 2026, $UTHR shares traded between roughly $518 and $563.